Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Horizon Therapeutics (HZNP)

76.35   1.02 (1.35%) 09-25 10:31
Open: 75.69 Pre. Close: 75.33
High: 76.35 Low: 74.8
Volume: 355,178 Market Cap: 16,823M
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 1,175 full-time employees. The firm is focused on researching, developing and commercializing medicines that address needs for people impacted by rare and rheumatic diseases. The firm markets approximately 10 medicines, of which 6 are for rare and rheumatic diseases. The firm's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 79.311 - 79.696 79.696 - 80.076
Low: 72.794 - 73.256 73.256 - 73.712
Close: 74.461 - 75.205 75.205 - 75.938

Technical analysis

as of: 2020-09-25 9:59:16 AM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 96.48     One year: 112.68
Support: Support1: 72.65    Support2: 66.50
Resistance: Resistance1: 82.60    Resistance2: 96.48
Pivot: 75.57
Moving Average: MA(5): 77.46     MA(20): 75.21
MA(100): 60.65     MA(250): 43.69
MACD: MACD(12,26): 1.89     Signal(9): 2.16
Stochastic oscillator: %K(14,3): 63.73     %D(3): 72.66
RSI: RSI(14): 51.68
52-week: High: 82.60  Low: 23.81  Change(%): 176.1
Average Vol(K): 3-Month: 228208  10-Days: 242529

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HZNP has closed above bottom band by 47.1%. Bollinger Bands are 27.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 25 Sep 2020
Where Does Horizon Therapeutics PLC (HZNP) Stock Fall in the Drug Manufacturers - General Field? - InvestorsObserver

Thu, 24 Sep 2020
Horizon Therapeutics Public Limited Company (HZNP) Plunges 5.58% on September 24 - Equities.com

Thu, 24 Sep 2020
How Much Did Horizon Therapeutics’ (NASDAQ:HZNP) CEO Pocket Last Year? - Simply Wall St

Wed, 23 Sep 2020
This Biotech Stock Hits Record High As Sales Of New Drug Top Views - Investor's Business Daily

Tue, 22 Sep 2020
The Rejuvenation of Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) - oracledispatch.com

Mon, 21 Sep 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 220
Shares Float (M) 204
% Held by Insiders 1.31
% Held by Institutions 91.66
Shares Short (K) 4,080
Shares Short P. Month (K) 4,790

Stock Financials

EPS 2.550
EPS Est This Year 1.070
EPS Est Next Year 1.250
Book Value (p.s.) 11.830
Profit Margin 34.09
Operating Margin 8.22
Return on Assets (ttm) 1.9
Return on Equity (ttm) 26.6
Qtrly Rev. Growth 44.3
Gross Profit (p.s.) 4.257
Sales Per Share 6.898
EBITDA (p.s.) 0.647
Qtrly Earnings Growth
Operating Cash Flow (M) 316
Levered Free Cash Flow (M) 240

Stock Valuations

PE Ratio 29.48
PEG Ratio
Price to Book value 6.35
Price to Sales 10.90
Price to Cash Flow 52.43

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.